
Super Vilitra
Vardenafil + Dapoxetine
Dispatched in 1 working day
Active ingredient
Vardenafil is a prescription-only medicine in the EU/EEA for erectile dysfunction in adult men, and the active substance of Levitra. Like sildenafil and tadalafil it is a PDE5 inhibitor, and sexual stimulation is still needed. The EU product information recommends 10 mg about 25 to 60 minutes before sex, with a maximum of 20 mg once a day.
Reviewed by the Kam4eu editorial team on 13 August 2026 · Next review August 2027
6 generic Vardenafil products — same molecule, different brands, formats and pack sizes.

Vardenafil + Dapoxetine
Dispatched in 1 working day

Vardenafil
Dispatched in 1 working day

Vardenafil
Dispatched in 1 working day

Vardenafil
Dispatched in 1 working day

Vardenafil
Dispatched in 1 working day

Vardenafil
Dispatched in 1 working day
Source: EMA — Levitra (vardenafil) product information (EU SmPC)
The four PDE5 inhibitors used for erectile dysfunction, compared on what each one's EU product information (Summary of Product Characteristics) states for adult men. Viagra, Cialis, Levitra and Spedra, the EU-authorised PDE5 inhibitors, are prescription-only under their EU authorisations — your doctor chooses the medicine and dose.
| Medicine | When to take | Response window | EU maximum dose | Food | Source |
|---|---|---|---|---|---|
| SildenafilOriginator: Viagra | About 1 hour before sexual activity | Erections still produced 4–5 hours after the dose (clinical study) | 100 mg, at most once a day | Taking it with food may delay the onset of effect | Viagra SmPC (EMA) |
| TadalafilOriginator: Cialis | At least 30 minutes before sexual activity | Improved erectile function up to 36 hours after the dose | 20 mg on demand, at most once a day | Absorption not affected by food — with or without a meal | Cialis SmPC (EMA) |
| VardenafilOriginator: Levitra | About 25 to 60 minutes before sexual activity | Better success than placebo when sex was attempted 4–5 hours after the dose | 20 mg, at most once a day | With or without food; a high-fat meal may delay the onset | Levitra SmPC (EMA) |
| AvanafilOriginator: Spedra | About 15 to 30 minutes before sexual activity | Not stated in the EU product information | 200 mg, at most once a day | Taking it with food may delay the onset of effect | Spedra SmPC (EMA) |
Source: EMA — Levitra (vardenafil) product information (EU SmPC)
Source: EMA — Levitra (vardenafil) product information (EU SmPC)
Vardenafil inhibits the PDE5 enzyme, allowing cyclic guanosine monophosphate (cGMP) to accumulate so that the blood vessels in the penis relax and blood flow improves during sexual stimulation. Sexual arousal is still necessary for the medicine to produce an effect. In clinical studies summarised in the EU product information for Levitra, sex attempted 4 to 5 hours after a dose was still more successful than with placebo.
Vardenafil is taken by mouth a short while before planned sexual activity, at the dose advised by your doctor. It can be taken with or without food, though a high-fat meal may slow how quickly it begins to work. No more than one dose should be taken in any 24-hour period. Always follow the patient information leaflet and the advice of your doctor or pharmacist.
The EU product information lists headache as very common (reported by 10% of men or more) and dizziness, flushing, nasal congestion and indigestion (dyspepsia) as common (1 to 10 in 100). Reactions in clinical trials were generally transient and mild to moderate.
Source: EMA — Levitra (vardenafil) product information (EU SmPC)
Common (usually mild and temporary):
Stop and seek medical help if you experience:
Store in the original packaging at room temperature, out of the sight and reach of children, and do not use after the expiry date.
In the EU, Levitra is authorised as 5 mg, 10 mg and 20 mg film-coated tablets and a 10 mg orodispersible tablet that dissolves in the mouth. The EU product information recommends 10 mg, adjusted to 5 mg or 20 mg depending on effect and tolerability. The 10 mg orodispersible tablet is not bioequivalent to the 10 mg film-coated tablet, so the two are not interchangeable.
Both exceed the EU maximum. The Levitra product information sets a maximum recommended dose of 20 mg, at most once a day, and tablets of 40 mg or 60 mg are not covered by that EU authorisation. The SmPC reports severe back pain when vardenafil was taken in higher doses and more often than recommended (40 mg twice daily). Only a doctor should decide whether any strength above 20 mg is appropriate for you.
According to the EU product information, headache is very common, and dizziness, flushing, nasal congestion and indigestion are common; most reactions are transient and mild to moderate. Men aged 65 or over taking 20 mg had more headaches and dizziness. Stop and get medical help at once for sudden loss of vision or hearing, chest pain, a severe skin reaction or a prolonged, painful erection — in an emergency call 112.
Vardenafil, present as vardenafil hydrochloride. Levitra has held an EU-wide marketing authorisation since March 2003. A generic product contains the same active substance, but only medicines with an EU or national marketing authorisation have been assessed by a European regulator. Vardenafil is prescription-only in the EU/EEA.
The EU product information for the reference medicine (Levitra) says to take it about 25 to 60 minutes before sexual activity. Timing varies between individuals, and a high-fat meal may delay the onset. See the patient information leaflet for details.
The Levitra package leaflet notes that alcoholic drinks can make erection difficulties worse, so it is sensible to be cautious. Your doctor or pharmacist can advise.
Vardenafil is the active ingredient and the generic equivalent of the branded medicine Levitra; both contain the same active substance and work in the same way.
Important: This information is general and not a substitute for medical advice. Always read the patient information leaflet supplied with your medicine and consult a doctor or pharmacist before use — especially if you have existing health conditions or take other medication.
European Medicines Agency assessment of the reference medicine.
Peer-reviewed clinical pharmacology of the whole drug class.
The EU Summary of Product Characteristics: strengths, the 20 mg maximum dose, contraindications, QT warning, interactions and side-effect frequencies.
Summary: Vardenafil, sold as Vilitra, is a PDE5 inhibitor like sildenafil and tadalafil. It helps erections only with arousal and is taken on demand before sex. Its working window is closer to sildenafil's than to tadalafil's long effect. The EU reference medicine is Levitra; never combine vardenafil with nitrates or another ED tablet.
Read guideSummary: Vardenafil, the active ingredient in Levitra, is a PDE5 inhibitor that helps erections during sexual arousal. The EMA product information for Levitra advises taking it about 25 to 60 minutes before sexual activity, and a fatty meal can delay it. It is shorter-acting than tadalafil, similar to sildenafil, and must never be combined with nitrates.
Read guideSummary: Snovitra is a generic brand of vardenafil, the active ingredient in Levitra and one of the three main ED medicines alongside sildenafil and tadalafil. It only works with sexual stimulation. The EMA product information for Levitra advises taking vardenafil about 25 to 60 minutes before sex. It must never be combined with nitrates.
Read guideSummary: Vilitra is generic vardenafil, the active ingredient in Levitra, a PDE5 inhibitor with a similar profile to sildenafil. Its window is shorter than tadalafil's. The EMA product information for Levitra advises taking it about 25 to 60 minutes before sex, with 20mg the maximum dose. Some men tolerate it better than other options. Never combine with nitrates.
Read guideConditions Vardenafil treats
Other treatments for the same conditions